Oxytroflavoside ACAS# 1391144-80-1 |
Quality Control & MSDS
Package In Stock
Number of papers citing our products
| Cas No. | 1391144-80-1 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Powder |
| Formula | C34H40O19 | M.Wt | 752.7 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Oxytroflavoside A Dilution Calculator
Oxytroflavoside A Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.3286 mL | 6.6428 mL | 13.2855 mL | 26.571 mL | 33.2138 mL |
| 5 mM | 0.2657 mL | 1.3286 mL | 2.6571 mL | 5.3142 mL | 6.6428 mL |
| 10 mM | 0.1329 mL | 0.6643 mL | 1.3286 mL | 2.6571 mL | 3.3214 mL |
| 50 mM | 0.0266 mL | 0.1329 mL | 0.2657 mL | 0.5314 mL | 0.6643 mL |
| 100 mM | 0.0133 mL | 0.0664 mL | 0.1329 mL | 0.2657 mL | 0.3321 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 12beta-Acetoxy-3beta-hydroxy-7,11,15,23-tetraoxo-lanost-8,20-diene-26-oic acid
Catalog No.:BCN0830
CAS No.:1085338-75-5
- Oxytroflavoside E
Catalog No.:BCN0829
CAS No.:1391144-84-5
- Pinocembrin 7-O-(4'',6''-hexahydroxydiphenoyl)-beta-D-glucose
Catalog No.:BCN0828
CAS No.:1825287-22-6
- Cannabisin P
Catalog No.:BCN0827
CAS No.:2756983-19-2
- Oblonganoside D
Catalog No.:BCN0826
CAS No.:943021-91-8
- 10-Carboxyloganin
Catalog No.:BCN0825
CAS No.:182172-02-7
- Gambogic acid A
Catalog No.:BCN0824
CAS No.:1592842-93-7
- 10-Hydroxyaloin B
Catalog No.:BCN0823
CAS No.:134863-92-6
- 10-Methoxygambogenic acid
Catalog No.:BCN0822
CAS No.:2095102-72-8
- 3beta-Hydroxyurs-12,18-dien-28-oic acid beta-D-glucopyranosyl ester
Catalog No.:BCN0821
CAS No.:434942-42-4
- 3beta-(alpha-L-Arabinopyranosyloxy)urs-12,18-dien-28-oic acid beta-D-glucopyranosyl ester
Catalog No.:BCN0820
CAS No.:435269-07-1
- Barbaloin-related compound B
Catalog No.:BCN0819
CAS No.:473225-22-8
- Gardoside methyl ester
Catalog No.:BCN0832
CAS No.:93930-20-2
- Ganoderenic acid K
Catalog No.:BCN0833
CAS No.:942950-94-9
- 2,6-Dihydroxyacetophenone-4-O-[4',6'-(S)-hexahydroxydiphenoyl]-beta-D-glucose
Catalog No.:BCN0834
CAS No.:1781226-44-5
- Ganolucidic acid D
Catalog No.:BCN0835
CAS No.:102607-22-7
- Rhamnocitrin 3-galactoside
Catalog No.:BCN0836
CAS No.:99878-05-4
- Otobaphenol
Catalog No.:BCN0837
CAS No.:10240-16-1
- 8-Epiloganin
Catalog No.:BCN0838
CAS No.:79172-04-6
- Isosecotanapartholide
Catalog No.:BCN0839
CAS No.:102926-01-2
- Malabaricone C
Catalog No.:BCN0840
CAS No.:63335-25-1
- Baishouwubenzophenone
Catalog No.:BCN0841
CAS No.:115834-34-9
- Malabaricone A
Catalog No.:BCN0842
CAS No.:63335-23-9
- Silybin A
Catalog No.:BCN0843
CAS No.:36804-17-8
Comparison of Phenolic Metabolites in Purified Extracts of Three Wild-Growing Herniaria L. Species and Their Antioxidant and Anti-Inflammatory Activities In Vitro.[Pubmed:35056848]
Molecules. 2022 Jan 14;27(2). pii: molecules27020530.
The work is aimed at phytochemical characterization and In Vitro evaluation of antioxidant actions, anti-inflammatory effects, and cytotoxicity of purified extracts from three rupturewort (Herniaria L.) species, i.e., Herniaria glabra (HG), H. polygama (HP), and H. incana herb (HIh). The total phenolic content established in the purified extracts (PEs) of HIh, HP, and HG was 29.6, 24.0, and 13.0%, respectively. Thirty-eight non-saponin metabolites were identified using LC-HR-QTOF-ESI-MS; however, only 9 were common for the studied Herniaria species. The most abundant phenolic compound in HG-PE was narcissin (7.4%), HP-PE shared 3 major constituents, namely cis-2-hydroxy-4-methoxycinnamic acid 2-O-beta-glucoside (cis-GMCA, 5.8%), narcissin (5.4%), and rutin (5.3%). Almost half of HIh phenolic content (14.7%) belonged to Oxytroflavoside A (7-O-methylkaempferol-3-O-[3-hydroxy-3-methylglutaryl-(1-->6)]-[alpha-rhamnopyran osyl-(1-->2)]-beta-galactopyranoside). Antioxidant properties of the Herniaria PEs were evaluated employing an experimental model of human blood plasma, exposed to the peroxynitrite-induced oxidative stress. The assays demonstrated significant reduction of oxidative damage to protein and lipid plasma components (estimated by measurements of 3-nitrotyrosine, protein thiol groups, thiobarbituric acid-reactive substances), and moderate protection of its non-enzymatic antioxidant capacity. Anti-inflammatory properties of the Herniaria PEs were evaluated In Vitro as inhibitory effects against cyclooxygenases (COX-1 and -2) and concanavalin A-induced inflammatory response of the peripheral blood mononuclear cells (PBMCs). None of the studied plants showed inhibitory effects on COXs but all purified extracts partly reduced the release of interleukin 2 (IL-2) and tumor necrosis factor-alpha (TNF-alpha) from PBMCs, which suggested their prospective ability to up-regulate inflammatory response of the cells. The purified extract from H. glabra turned out to be the most efficient suppressor of PBMCs' inflammatory response. Additionally, cytotoxicity of purified Herniaria extracts on PBMCs was ruled out based on In Vitro studies.
